- Can thymidine phosphorylase be a predictive marker for gemcitabine and doxifluridine combination chemotherapy in cholangiocarcinoma?: case series. Kang, M.H., Lee, W.S., Go, S.I., Kim, M.J., Lee, U.S., Choi, H.J., Kim, D.C., Lee, J.H., Kim, H.G., Bae, K.S., Cho, J.M. Medicine. (Baltimore) (2014)